Nissay Asset Management Corp Japan ADV Buys 1,097 Shares of Henry Schein, Inc. (NASDAQ:HSIC)
Nissay Asset Management Corp Japan ADV increased its stake in Henry Schein, Inc. (NASDAQ:HSIC) by 8.3% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 14,325 shares of the company’s stock after acquiring an additional 1,097 shares during the period. Nissay Asset Management Corp Japan ADV’s holdings in Henry Schein were worth $836,000 as of its most recent SEC filing.
A number of other hedge funds also recently modified their holdings of the stock. Wellington Management Group LLP boosted its holdings in Henry Schein by 92.3% in the first quarter. Wellington Management Group LLP now owns 59,483 shares of the company’s stock worth $3,005,000 after acquiring an additional 28,548 shares in the last quarter. MERIAN GLOBAL INVESTORS UK Ltd boosted its holdings in Henry Schein by 79.0% in the second quarter. MERIAN GLOBAL INVESTORS UK Ltd now owns 184,569 shares of the company’s stock worth $10,776,000 after acquiring an additional 81,453 shares in the last quarter. Vident Investment Advisory LLC boosted its holdings in Henry Schein by 4.0% in the second quarter. Vident Investment Advisory LLC now owns 51,665 shares of the company’s stock worth $3,017,000 after acquiring an additional 1,977 shares in the last quarter. BlackRock Inc. lifted its holdings in shares of Henry Schein by 7.5% during the first quarter. BlackRock Inc. now owns 12,003,432 shares of the company’s stock valued at $606,414,000 after purchasing an additional 837,255 shares in the last quarter. Finally, PGGM Investments lifted its holdings in shares of Henry Schein by 16.2% during the second quarter. PGGM Investments now owns 433,067 shares of the company’s stock valued at $25,287,000 after purchasing an additional 60,433 shares in the last quarter.
In other Henry Schein news, VP Walter Siegel sold 1,149 shares of the firm’s stock in a transaction that occurred on Friday, June 5th. The shares were sold at an average price of $65.00, for a total transaction of $74,685.00. Following the sale, the vice president now owns 51,620 shares in the company, valued at approximately $3,355,300. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 1.05% of the company’s stock.
Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings results on Tuesday, May 5th. The company reported $0.94 EPS for the quarter, topping analysts’ consensus estimates of $0.74 by $0.20. Henry Schein had a return on equity of 15.19% and a net margin of 7.11%. The business had revenue of $2.43 billion during the quarter, compared to analysts’ expectations of $2.32 billion. During the same quarter in the prior year, the business posted $0.80 earnings per share. The business’s quarterly revenue was up 2.9% on a year-over-year basis. As a group, sell-side analysts predict that Henry Schein, Inc. will post 2.14 EPS for the current fiscal year.
A number of brokerages have recently issued reports on HSIC. Barrington Research downgraded Henry Schein from an “outperform” rating to a “market perform” rating in a report on Wednesday, May 6th. UBS Group lowered their price target on Henry Schein from $60.00 to $50.00 and set a “sell” rating on the stock in a report on Thursday, May 7th. Cfra lowered their price target on Henry Schein from $69.00 to $60.00 and set a “hold” rating on the stock in a report on Tuesday, May 5th. TheStreet raised Henry Schein from a “c+” rating to a “b-” rating in a report on Thursday, July 16th. Finally, Robert W. Baird upped their price target on Henry Schein from $58.00 to $60.00 and gave the company a “neutral” rating in a report on Wednesday, May 6th. Three investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and four have given a buy rating to the stock. Henry Schein currently has a consensus rating of “Hold” and an average target price of $64.33.
Henry Schein Company Profile
Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Featured Article: What are high-yield dividend stocks?
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.